| scholarly article | Q13442814 |
| P2093 | author name string | Jung Soo Suk | |
| Laura M Ensign | |||
| Qingguo Xu | |||
| Namho Kim | |||
| P2860 | cites work | Evading immune cell uptake and clearance requires PEG grafting at densities substantially exceeding the minimum for brush conformation. | Q53621609 |
| Micro- and macrorheology of mucus | Q24643968 | ||
| Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery | Q26823541 | ||
| Anti-PEG immunity: emergence, characteristics, and unaddressed questions | Q26825556 | ||
| Mucoadhesive nanoparticles may disrupt the protective human mucus barrier by altering its microstructure | Q27334360 | ||
| Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase | Q28257553 | ||
| A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
| Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy | Q28383844 | ||
| Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain | Q28394137 | ||
| Biomolecular coronas provide the biological identity of nanosized materials | Q29615557 | ||
| Recent advances with liposomes as pharmaceutical carriers | Q29616702 | ||
| Mechanisms of phagocytosis in macrophages | Q29618100 | ||
| Non-invasive delivery of stealth, brain-penetrating nanoparticles across the blood-brain barrier using MRI-guided focused ultrasound. | Q30370894 | ||
| Role of target geometry in phagocytosis | Q30477258 | ||
| Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus | Q30478934 | ||
| Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles | Q30497897 | ||
| A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue | Q30541682 | ||
| Use of single-site-functionalized PEG dendrons to prepare gene vectors that penetrate human mucus barriers | Q30546346 | ||
| Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). | Q30729351 | ||
| Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. | Q30837863 | ||
| Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications | Q30866277 | ||
| Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. | Q31096180 | ||
| An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. | Q31116672 | ||
| Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. | Q31161948 | ||
| Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release | Q33219684 | ||
| Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells | Q33269975 | ||
| Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery | Q33270241 | ||
| Contribution of high-resolution correlative imaging techniques in the study of the liver sieve in three-dimensions | Q33272087 | ||
| PEGylated dendritic unimolecular micelles as versatile carriers for ligands of G protein-coupled receptors | Q33507142 | ||
| Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses | Q33640386 | ||
| Effect of the poly(ethylene glycol) (PEG) density on the access and uptake of particles by antigen-presenting cells (APCs) after subcutaneous administration | Q37360660 | ||
| Barrier properties of mucus | Q37365829 | ||
| Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues | Q48520331 | ||
| Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy | Q48735724 | ||
| Sizing nanomatter in biological fluids by fluorescence single particle tracking | Q49087618 | ||
| High-intensity focused ultrasound for the treatment of liver tumours | Q50250410 | ||
| Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes. | Q51458666 | ||
| Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats. | Q51483253 | ||
| Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. | Q52052010 | ||
| Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins. | Q53309572 | ||
| PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression | Q37378029 | ||
| Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. | Q37429043 | ||
| PEGylated PLGA nanoparticles for the improved delivery of doxorubicin | Q37463836 | ||
| Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. | Q37467770 | ||
| Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles | Q37570199 | ||
| Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier | Q37633436 | ||
| Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects | Q37771342 | ||
| Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives | Q37774596 | ||
| A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. | Q37788834 | ||
| Influence of dendrimers on red blood cells. | Q37956522 | ||
| Recent advances in stealth coating of nanoparticle drug delivery systems | Q37974590 | ||
| The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors. | Q38111201 | ||
| The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. | Q38128105 | ||
| Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status | Q38135674 | ||
| Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics | Q38247831 | ||
| Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions | Q38288939 | ||
| Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles | Q38525935 | ||
| Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats | Q38548001 | ||
| Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats | Q38568135 | ||
| Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
| Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting | Q38906057 | ||
| Engineering poly(ethylene glycol) particles for improved biodistribution | Q38906318 | ||
| Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology | Q39093144 | ||
| Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration | Q39113394 | ||
| Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface | Q39207806 | ||
| Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application | Q39286168 | ||
| Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake | Q39423946 | ||
| Cellular delivery of PEGylated PLGA nanoparticles | Q39431636 | ||
| Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles | Q39527615 | ||
| Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy | Q39542270 | ||
| Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. | Q39577426 | ||
| Chondroitin Sulfate Capsule System for Efficient and Secure Gene Delivery | Q39629633 | ||
| PLGA/polymeric liposome for targeted drug and gene co-delivery | Q39665100 | ||
| The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses | Q39780919 | ||
| Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 | ||
| Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity | Q39972148 | ||
| Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth | Q33763847 | ||
| PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo | Q33815847 | ||
| Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers. | Q33816969 | ||
| Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces | Q33852932 | ||
| Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. | Q34028841 | ||
| State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines | Q34045119 | ||
| Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses | Q34067641 | ||
| PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics | Q34149180 | ||
| In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis | Q34170404 | ||
| Diffusion of macromolecules and virus-like particles in human cervical mucus | Q34176484 | ||
| Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. | Q34227677 | ||
| Nanopharmaceuticals (part 1): products on the market | Q34230175 | ||
| Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy | Q34241388 | ||
| Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
| Nanoparticle penetration of human cervicovaginal mucus: the effect of polyvinyl alcohol. | Q34324995 | ||
| Brain-penetrating nanoparticles improve paclitaxel efficacy in malignant glioma following local administration | Q34419922 | ||
| Microfluidic technologies for accelerating the clinical translation of nanoparticles | Q34435740 | ||
| Immobilization of pseudorabies virus in porcine tracheal respiratory mucus revealed by single particle tracking | Q34510728 | ||
| Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo | Q34550075 | ||
| In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space | Q34600402 | ||
| Polymer-drug conjugates: recent development in clinical oncology | Q34656003 | ||
| Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse | Q34749181 | ||
| Minimizing the non-specific binding of nanoparticles to the brain enables active targeting of Fn14-positive glioblastoma cells | Q34785621 | ||
| Targeting kidney mesangium by nanoparticles of defined size | Q34835611 | ||
| Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus | Q35002405 | ||
| Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200 nm. | Q35011373 | ||
| Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus | Q35087552 | ||
| Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI). | Q35088353 | ||
| Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies | Q35124674 | ||
| Nanoparticle PEGylation for imaging and therapy | Q35553193 | ||
| In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery | Q35563449 | ||
| N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. | Q35568532 | ||
| "Clickable", polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions | Q35606153 | ||
| Transport of nanoparticles across the rat nasal mucosa. | Q53677556 | ||
| Serum independent liposome uptake by mouse liver. | Q53746035 | ||
| Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes | Q56386325 | ||
| Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon | Q56897495 | ||
| Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems | Q57344455 | ||
| Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes | Q57779762 | ||
| ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption | Q60775760 | ||
| Stealth PLA-PEG nanoparticles as protein carriers for nasal administration | Q60775904 | ||
| Pharmacokinetics of curcumin-loaded PLGA and PLGA–PEG blend nanoparticles after oral administration in rats | Q61047002 | ||
| The chemical modification of liposome surfaces via a copper-mediated [3 + 2] azide–alkyne cycloaddition monitored by a colorimetric assay | Q61399932 | ||
| PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution | Q61787443 | ||
| Intravenous administration of polyethylene glycol-coated (PEGylated) proteins and PEGylated adenovirus elicits an anti-PEG immunoglobulin M response | Q64379054 | ||
| Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo | Q70213084 | ||
| Acrylic microspheres in vivo IX: Blood elimination kinetics and organ distribution of microparticles with different surface characteristics | Q71171282 | ||
| Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors | Q71298948 | ||
| Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators | Q71616818 | ||
| Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System | Q71943642 | ||
| Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter | Q73339605 | ||
| Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles | Q73482289 | ||
| Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption | Q73503867 | ||
| Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes | Q79162893 | ||
| Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection | Q79256002 | ||
| Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA | Q80146633 | ||
| The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats | Q80411581 | ||
| PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner | Q80567468 | ||
| Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes | Q81453578 | ||
| Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA | Q81547115 | ||
| Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes | Q82724162 | ||
| Decorated rods: a "bottom-up" self-assembly of monomolecular DNA complexes | Q82775001 | ||
| Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA | Q83169044 | ||
| Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles | Q84295405 | ||
| Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies | Q84381308 | ||
| Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods | Q84528928 | ||
| Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity | Q84557024 | ||
| Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon | Q85006323 | ||
| On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein | Q85192752 | ||
| In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration | Q86408525 | ||
| Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials. | Q35624010 | ||
| Highly compacted DNA nanoparticles with low MW PEG coatings: in vitro, ex vivo and in vivo evaluation. | Q35631652 | ||
| A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles | Q35634184 | ||
| The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes | Q35669424 | ||
| Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies | Q35684362 | ||
| Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles | Q35759073 | ||
| Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers | Q35877982 | ||
| Serum opsonins and liposomes: their interaction and opsonophagocytosis | Q35900905 | ||
| Real-time multiple-particle tracking: applications to drug and gene delivery | Q35935127 | ||
| Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages | Q36048542 | ||
| Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles | Q36319725 | ||
| Parameters influencing the stealthiness of colloidal drug delivery systems | Q36464936 | ||
| Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | Q36477445 | ||
| Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. | Q36497423 | ||
| Nanoparticle diffusion in respiratory mucus from humans without lung disease | Q36664260 | ||
| Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time | Q36800814 | ||
| Sheddable coatings for long-circulating nanoparticles | Q36841604 | ||
| Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer | Q36851453 | ||
| Macrophage complement receptors and pathogen clearance | Q36859212 | ||
| Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo | Q36961634 | ||
| Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles | Q36970889 | ||
| Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues | Q37011581 | ||
| Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain | Q37019334 | ||
| Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution | Q37036373 | ||
| Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus | Q37062353 | ||
| Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical mucus | Q37087457 | ||
| The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles. | Q37141909 | ||
| Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Q37146591 | ||
| Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier | Q37153146 | ||
| Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues | Q37153923 | ||
| PEGylation of nanoparticles improves their cytoplasmic transport | Q37178559 | ||
| Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas | Q37267361 | ||
| Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus | Q37280337 | ||
| Biodegradable mucus-penetrating nanoparticles composed of diblock copolymers of polyethylene glycol and poly(lactic-co-glycolic acid) | Q37281441 | ||
| Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection | Q40212490 | ||
| Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake | Q40266642 | ||
| Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors | Q40301749 | ||
| Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors | Q40366033 | ||
| Monoclonal antibody-based quantitation of poly(ethylene glycol)-derivatized proteins, liposomes, and nanoparticles | Q40371074 | ||
| PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization | Q40413171 | ||
| PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles | Q40544301 | ||
| Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures | Q40640731 | ||
| The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration | Q40755265 | ||
| Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs | Q40905791 | ||
| Interactions between a macrophage cell line (J774A1) and surface-modified poly (D,L-lactide) nanocapsules bearing poly(ethylene glycol). | Q40909460 | ||
| Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting | Q40947914 | ||
| Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery | Q41130823 | ||
| Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo | Q41587469 | ||
| Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. | Q41624755 | ||
| Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats | Q41839677 | ||
| Role of the methoxy group in immune responses to mPEG-protein conjugates | Q41940240 | ||
| The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. | Q42011060 | ||
| Adenoviral vectors coated with cationic PEG derivatives for intravaginal vaccination against HIV-1. | Q42210438 | ||
| Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery. | Q42248514 | ||
| Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution | Q42473767 | ||
| Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system | Q42812609 | ||
| Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA. | Q42829191 | ||
| Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery | Q42920619 | ||
| The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses | Q43271145 | ||
| PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats | Q43557085 | ||
| Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles. | Q43619798 | ||
| CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes | Q43646936 | ||
| Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug. | Q43993972 | ||
| Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery | Q44038921 | ||
| Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake | Q44054856 | ||
| Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability | Q44435875 | ||
| PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route | Q44624146 | ||
| 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug | Q44836606 | ||
| PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease | Q44838450 | ||
| Polyethylene glycol-grafted polystyrene particles | Q44918645 | ||
| Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan | Q44955434 | ||
| Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles. | Q45067177 | ||
| Unimolecular micelles based on hydrophobically derivatized hyperbranched polyglycerols: biodistribution studies | Q45373924 | ||
| Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents. | Q45717861 | ||
| PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. | Q45858804 | ||
| Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery | Q45889911 | ||
| The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. | Q45977543 | ||
| PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery | Q46181738 | ||
| Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection | Q46738424 | ||
| Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time | Q46750154 | ||
| Comparison of electrospray ionization mass spectrometry and evaporative light scattering detections for the determination of Poloxamer 188 in itraconazole injectable formulation. | Q46927967 | ||
| Immunoaffinity purification using anti-PEG antibody followed by two-dimensional liquid chromatography/tandem mass spectrometry for the quantification of a PEGylated therapeutic peptide in human plasma | Q46983919 | ||
| Particle size-dependent triggering of accelerated blood clearance phenomenon | Q47227738 | ||
| In vivo biological evaluation of high molecular weight hyperbranched polyglycerols. | Q47273959 | ||
| In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size | Q47369583 | ||
| Microfluidic platform for controlled synthesis of polymeric nanoparticles | Q47429457 | ||
| Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method | Q47758963 | ||
| Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action | Q47961851 | ||
| In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content | Q48010833 | ||
| Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production | Q48019983 | ||
| P433 | issue | Pt A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 28-51 | |
| P577 | publication date | 2015-10-06 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | PEGylation as a strategy for improving nanoparticle-based drug and gene delivery | |
| P478 | volume | 99 |
| Q57049381 | A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics |
| Q89975524 | A Facile One-Pot Synthesis of Versatile PEGylated Platinum Nanoflowers and Their Application in Radiation Therapy |
| Q91708957 | A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications |
| Q39026756 | A Model for the Transient Subdiffusive Behavior of Particles in Mucus |
| Q51262828 | A Versatile and Clearable Nanocarbon Theranostic Based on Carbon Dots and Gadolinium Metallofullerene Nanocrystals. |
| Q99565661 | A combined "eat me/don't eat me" strategy based on extracellular vesicles for anticancer nanomedicine |
| Q92181134 | A non-sacrificial method for the quantification of poly(ethylene glycol) grafting density on gold nanoparticles for applications in nanomedicine |
| Q39117236 | A novel strategy to achieve effective drug delivery: exploit cells as carrier combined with nanoparticles |
| Q64265722 | A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine |
| Q37042592 | A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation |
| Q98513637 | A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection |
| Q89736557 | Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting Ligand |
| Q91603851 | Adapting liposomes for oral drug delivery |
| Q55349305 | Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica. |
| Q98386176 | Advances in oligonucleotide drug delivery |
| Q102327940 | Aldehyde-Functionalized Magnetic Particles to Capture Off-Target Chemotherapeutic Agents |
| Q53659725 | Aliphatic Polyethers with Sulfate, Carboxylate, and Hydroxyl Side Groups-Do They Show Anticoagulant Properties? |
| Q90178832 | Anti-tumor effect of PEG-coated PLGA nanoparticles of febuxostat on A549 non-small cell lung cancer cells |
| Q92663461 | Antiretroviral Hydrophobic Core Graft-Copolymer Nanoparticles: The Effectiveness against Mutant HIV-1 Strains and in Vivo Distribution after Topical Application |
| Q38708389 | Apoferritin as an ubiquitous nanocarrier with excellent shelf life. |
| Q90289038 | Application of Paclitaxel-loaded EGFR Peptide-conjugated Magnetic Polymeric Liposomes for Liver Cancer Therapy |
| Q95840227 | Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis |
| Q64066446 | Applications of daunorubicin-loaded PLGA-PLL-PEG-Tf nanoparticles in hematologic malignancies: an in vitro and in vivo evaluation |
| Q89040183 | Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art |
| Q28829736 | Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma |
| Q29248141 | Barriers to inhaled gene therapy of obstructive lung diseases: A review |
| Q99629355 | Beyond Cisplatin: Combination Therapy with Arsenic Trioxide |
| Q38685603 | Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors |
| Q92407803 | Biomimetic Nanotherapies: Red Blood Cell Based Core-Shell Structured Nanocomplexes for Atherosclerosis Management |
| Q39210548 | Biomimetic and bioinspired nanoparticles for targeted drug delivery |
| Q96110486 | Biomimetic anisotropic polymeric nanoparticles coated with red blood cell membranes for enhanced circulation and toxin removal |
| Q90055871 | Biomimetic nanoparticle technology for cardiovascular disease detection and treatment |
| Q60916218 | Biomolecules Turn Self-Assembling Amphiphilic Block Co-polymer Platforms Into Biomimetic Interfaces |
| Q46254890 | Black Phosphorus Quantum Dots with Renal Clearance Property for Efficient Photodynamic Therapy |
| Q93060777 | Block copolymer composition drives function of self-assembled nanoparticles for delivery of small-molecule cargo |
| Q92128794 | Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles |
| Q48291956 | Brain-Penetrating Nanoparticles for Analysis of the Brain Microenvironment |
| Q39233422 | Brain-Targeted Polymers for Gene Delivery in the Treatment of Brain Diseases |
| Q89895605 | Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System |
| Q38676164 | Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines. |
| Q50194388 | Brownian motion near an elastic cell membrane: A theoretical study. |
| Q63989258 | C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes |
| Q52628718 | Cell Membrane Coating Nanotechnology. |
| Q90168897 | Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy |
| Q51012259 | Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles. |
| Q92662564 | Chitosan Derivatives and Their Application in Biomedicine |
| Q91816169 | Circulating Extracellular Vesicles Containing Xenobiotic Metabolizing CYP Enzymes and Their Potential Roles in Extrahepatic Cells Via Cell-Cell Interactions |
| Q64112372 | Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent |
| Q89764199 | Clickable modular polysaccharide nanoparticles for selective cell-targeting |
| Q90353506 | Co-delivery of allergen epitope fragments and R848 inhibits food allergy by inducing tolerogenic dendritic cells and regulatory T cells |
| Q90246950 | Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles |
| Q42335701 | Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation |
| Q91090269 | Conjugation of Amine-Functionalized Polyesters With Dimethylcasein Using Microbial Transglutaminase |
| Q92582645 | Control of Cationic Nanogel PEGylation in Heterogeneous ARGET ATRP Emulsion Polymerization with PEG Macromonomers |
| Q90328483 | Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention |
| Q37652843 | Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone |
| Q89598886 | Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases |
| Q28821307 | Cytocompatible and multifunctional polymeric nanoparticles for transportation of bioactive molecules into and within cells |
| Q40252910 | DNA/RNA-based formulations for treatment of breast cancer. |
| Q38740618 | DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting |
| Q93055660 | Decreased nonspecific adhesivity, receptor-targeted therapeutic nanoparticles for primary and metastatic breast cancer |
| Q57795313 | Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation |
| Q89457941 | Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells |
| Q90633270 | Development of an advanced nanoformulation for the intracellular delivery of a caspase-3 selective activity-based probe |
| Q64115586 | Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice |
| Q90001865 | Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo |
| Q47444145 | Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery |
| Q42114884 | Distribution of PLGA-modified nanoparticles in 3D cell culture models of hypo-vascularized tumor tissue |
| Q54970083 | Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme. |
| Q47433079 | Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials |
| Q41561441 | Drug delivery approaches for breast cancer |
| Q47362437 | Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy |
| Q48298889 | Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics. |
| Q92095928 | Effect of TAT-DOX-PEG irradiated gold nanoparticles conjugates on human osteosarcoma cells |
| Q92465818 | Effects of PEGylated Fe-Fe3O4 core-shell nanoparticles on NIH3T3 and A549 cell lines |
| Q90397498 | Effects of functionalized silver nanoparticles on aggregation of human blood platelets |
| Q91905763 | Elaboration and characterization of curcumin-loaded Tri-CL-mPEG three-arm copolymeric nanoparticles by a microchannel technology |
| Q33838871 | Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes |
| Q92163696 | Emerging Two-Dimensional Nanomaterials for Cancer Therapy |
| Q27348342 | Emerging integrated nanoclay-facilitated drug delivery system for papillary thyroid cancer therapy |
| Q57489611 | Endogenously Triggerable Ultrasmall-in-Nano Architectures: Targeting Assessment on 3D Pancreatic Carcinoma Spheroids |
| Q92446089 | Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies |
| Q92523409 | Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer |
| Q58552610 | Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor |
| Q39230414 | Engineering exosomes as refined biological nanoplatforms for drug delivery |
| Q46311969 | Engineering of extracellular vesicles as drug delivery vehicles |
| Q47409412 | Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents. |
| Q90077905 | Enzyme-induced in vivo assembly of gold nanoparticles for imaging-guided synergistic chemo-photothermal therapy of tumor |
| Q92798173 | Exosomes as Therapeutic Vehicles for Cancer |
| Q90915689 | Exploring Factors for the Design of Nanoparticles as Drug Delivery Vectors |
| Q64086552 | Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking |
| Q26767267 | Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems |
| Q92110368 | Folic Acid Receptor-Mediated Targeting Enhances the Cytotoxicity, Efficacy, and Selectivity of Withania somnifera Leaf Extract: In vitro and in vivo Evidence |
| Q57178917 | Formation of a protein corona influences the biological identity of nanomaterials |
| Q92422800 | Functional Role of VCAM-1 Targeted Flavonoid-Loaded Lipid Nanoemulsions in Reducing Endothelium Inflammation |
| Q91579285 | Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona |
| Q92755988 | Functionalized Gold Nanoparticles as Contrast Agents for Proton and Dual Proton/Fluorine MRI |
| Q48240255 | Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications. |
| Q39027588 | Gene delivery nanoparticles to modulate angiogenesis |
| Q64068083 | Genetic Engineering of Bacteriophages Against Infectious Diseases |
| Q96765638 | Glycogen as an advantageous polymer carrier in cancer theranostics: Straightforward in vivo evidence |
| Q49499411 | Highly Stable, Ultra-Small Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability. |
| Q64249420 | Hybrid Nanogels: Stealth and Biocompatible Structures for Drug Delivery Applications |
| Q91393421 | Hypocrellin Derivative-Loaded Calcium Phosphate Nanorods as NIR Light-Triggered Phototheranostic Agents with Enhanced Tumor Accumulation for Cancer Therapy |
| Q64102814 | IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer |
| Q91722838 | IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies |
| Q52686015 | Impact of Anti-Biofouling Surface Coatings on the Properties of Nanomaterials and Their Biomedical Applications. |
| Q52561274 | Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - An illustration with firsthand examples. |
| Q90330221 | Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer |
| Q39114835 | Improved Targeting of Cancers with Nanotherapeutics |
| Q92644551 | Improving nanotherapy delivery and action through image-guided systems pharmacology |
| Q41599384 | Improving the Delivery of SOD1 Antisense Oligonucleotides to Motor Neurons Using Calcium Phosphate-Lipid Nanoparticles. |
| Q48245475 | In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer. |
| Q47334555 | In Vitro Evaluation of Anti-Aggregation and Degradation Behavior of PEGylated Polymeric Nanogels under In Vivo Like Conditions. |
| Q50012091 | In Vivo Pharmacokinetics of Magnetic Nanoparticles |
| Q58586414 | Inert Coats of Magnetic Nanoparticles Prevent Formation of Occlusive Intravascular Co-aggregates With Neutrophil Extracellular Traps |
| Q59146736 | Interaction of Solid Lipid Nanoparticles and Specific Proteins of the Corona Studied by Surface Plasmon Resonance |
| Q92122703 | Intracranial Non-thermal Ablation Mediated by Transcranial Focused Ultrasound and Phase-Shift Nanoemulsions |
| Q89570189 | Labelling primary immune cells using bright blue fluorescent nanoparticles |
| Q92858446 | Latest advances in extracellular vesicles: from bench to bedside |
| Q55150815 | Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy. |
| Q89129500 | Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis |
| Q39196485 | Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer |
| Q48225327 | Lipid-Based Nanoparticles as a Potential Delivery Approach in the Treatment of Rheumatoid Arthritis. |
| Q92145740 | Loading and Releasing Ciprofloxacin in Photoactivatable Liposomes |
| Q58769409 | Lysozyme and DNase I loaded poly (D, L lactide-co-caprolactone) nanocapsules as an oral delivery system |
| Q92501485 | M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma |
| Q30252977 | MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound |
| Q47814981 | MSAll strategy for comprehensive quantitative analysis of PEGylated-doxorubicin, PEG and doxorubicin by LC-high resolution q-q-TOF mass spectrometry coupled with all window acquisition of all fragment ion spectra |
| Q53697469 | Macrophage-Targeted Therapeutics for Metabolic Disease. |
| Q93200295 | Magnetic Temperature-Sensitive Solid-Lipid Particles for Targeting and Killing Tumor Cells |
| Q97419462 | Magnetically Directed Enzyme/Prodrug Prostate Cancer Therapy Based on β-Glucosidase/Amygdalin |
| Q90168870 | Magnetically controlled protein nanocontainers as a drug depot for the hemostatic agent |
| Q89553024 | Magnetite Nanoparticles Coated with PEG 3350-Tween 80: In Vitro Characterization Using Primary Cell Cultures |
| Q64093618 | Metabolically Active, Fully Hydrolysable Polymersomes |
| Q101051205 | Metal nanoparticle alters adenine induced charge transfer kinetics of vitamin K3 in magnetic field |
| Q100454961 | Micro-rheological properties of lung homogenates correlate with infection severity in a mouse model of Pseudomonas aeruginosa lung infection |
| Q28076754 | MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers |
| Q42284455 | Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma |
| Q61443749 | Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats |
| Q47114838 | Molecular targets in aortic aneurysm for establishing novel management paradigms |
| Q91815407 | Monitoring the Fate of Orally Administered PLGA Nanoformulation for Local Delivery of Therapeutic Drugs |
| Q89896117 | Monocytic Cell-Induced Phase Transformation of Circulating Lipid-Based Liquid Crystalline Nanosystems |
| Q51142243 | Multi-Responsive "Turn-On" Nanocarriers for Efficient Site-Specific Gene Delivery In Vitro and In Vivo. |
| Q90348651 | Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer |
| Q47121798 | Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy |
| Q47351188 | Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies |
| Q38802375 | Nanomedicines for renal disease: current status and future applications |
| Q91754431 | Nanoparticle Therapy for Vascular Diseases |
| Q33772186 | Nanoparticle-based drug delivery systems: What can they really do in vivo? |
| Q54212001 | Nanoparticle-mediated drug delivery to treat infections in the female reproductive tract: evaluation of experimental systems and the potential for mathematical modeling. |
| Q47930607 | Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention |
| Q55003489 | Nanoparticles in the clinic. |
| Q30844270 | Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation. |
| Q48540669 | Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma. |
| Q47818560 | Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses. |
| Q96127279 | Native and bioengineered extracellular vesicles for cardiovascular therapeutics |
| Q92153775 | Near Infrared-Activated Dye-Linked ZnO Nanoparticles Release Reactive Oxygen Species for Potential Use in Photodynamic Therapy |
| Q57065785 | Non-Viral Delivery To Enable Genome Editing |
| Q38703346 | Novel Focused Ultrasound Gene Therapy Approach Noninvasively Restores Dopaminergic Neuron Function in a Rat Parkinson's Disease Model |
| Q92980281 | Novel PEG-Modified Hybrid PLGA-Vegetable Oils Nanostructured Carriers for Improving Performances of Indomethacin Delivery |
| Q60935924 | Novel PEGylated Liposomes Enhance Immunostimulating Activity of isRNA |
| Q90163298 | Novel Tamoxifen Nanoformulations for Improving Breast Cancer Treatment: Old Wine in New Bottles |
| Q91961703 | Novel Tools towards Magnetic Guidance of Neurite Growth: (I) Guidance of Magnetic Nanoparticles into Neurite Extensions of Induced Human Neurons and In Vitro Functionalization with RAS Regulating Proteins |
| Q39095290 | Novel functionalization strategies to improve drug delivery from polymers. |
| Q61796135 | Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of Re radionuclide for cancer therapy |
| Q92852995 | Optimization of Polyarginine-Conjugated PEG Lipid Grafted Proliposome Formulation for Enhanced Cellular Association of a Protein Drug |
| Q92757761 | Optimizing pharmacokinetics of intravesical chemotherapy for bladder cancer |
| Q48120325 | Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract |
| Q91693455 | Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification |
| Q92542752 | Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet? |
| Q92403213 | PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy |
| Q40971346 | PEG-lipid micelles enable cholesterol efflux in Niemann-Pick Type C1 disease-based lysosomal storage disorder |
| Q64067023 | PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses |
| Q91640484 | PEGylated liposomes: immunological responses |
| Q89043471 | PEGylation of Carbonate Apatite Nanoparticles Prevents Opsonin Binding and Enhances Tumor Accumulation of Gemcitabine |
| Q47276253 | PEGylation of zinc nanoparticles amplifies their ability to enhance olfactory responses to odorant |
| Q47794249 | Particle Targeting in Complex Biological Media |
| Q92705174 | Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma |
| Q91669696 | Peptide-siRNA Supramolecular Particles for Neural Cell Transfection |
| Q58598420 | Physiologically-based pharmacokinetic modeling of nanoparticles |
| Q95273159 | Polymer nanoparticle-assisted chemotherapy of pancreatic cancer |
| Q58574610 | Polymeric materials and films in dentistry: An overview |
| Q100945795 | Preparation of parenteral nanocrystal suspensions of etoposide from the excipient free dry state of the drug to enhance in vivo antitumoral properties |
| Q90307169 | Preparation, Characterization, and Evaluation of Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved In Vitro and In Vivo Anticancer Activities |
| Q100512365 | Preparation, characterisation and biological evaluation of biopolymer-coated multi-walled carbon nanotubes for sustained-delivery of silibinin |
| Q40067237 | Probing the potential of mucus permeability to signify preterm birth risk |
| Q47885456 | Protein nanocages that penetrate airway mucus and tumor tissue |
| Q64094553 | Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy |
| Q125572088 | RETRACTED: Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol |
| Q94673028 | RNA Delivery via DNA-Inspired Janus Base Nanotubes for Extracellular Matrix Penetration |
| Q91875657 | Rate of Dimer Formation in Stable Colloidal Solutions Quantified Using an Attractive Interparticle Force |
| Q89259740 | Rationally Designed Polycationic Carriers for Potent Polymeric siRNA-Mediated Gene Silencing |
| Q92328323 | Recent Advances in Magnetite Nanoparticle Functionalization for Nanomedicine |
| Q92067523 | Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials |
| Q91669702 | Recent Advances in the Use of Focused Ultrasound for Magnetic Resonance Image-Guided Therapeutic Nanoparticle Delivery to the Central Nervous System |
| Q92235085 | Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications |
| Q64259300 | Red Blood Cell Membrane Bioengineered Zr-89 Labelled Hollow Mesoporous Silica Nanosphere for Overcoming Phagocytosis |
| Q61136923 | Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude |
| Q40997212 | Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration |
| Q90094407 | Reimaging biological barriers affecting distribution and extravasation of PEG/peptide- modified liposomes in xenograft SMMC7721 tumor |
| Q38719173 | Revisiting the role of sucrose in PLGA-PEG nanocarrier for potential intranasal delivery |
| Q92424099 | Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues |
| Q89112552 | Scalable Synthesis of Biodegradable Black Mesoporous Silicon Nanoparticles for Highly Efficient Photothermal Therapy |
| Q47810938 | Scale-dependent rotational diffusion of nanoparticles in polymer solutions |
| Q52315145 | Selective permeability of mucus barriers. |
| Q61951676 | Self-assembled, ellipsoidal polymeric nanoparticles for intracellular delivery of therapeutics |
| Q36141897 | Separation of polyethylene glycols and maleimide-terminated polyethylene glycols by reversed-phase liquid chromatography under critical conditions |
| Q92527656 | Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles |
| Q50959449 | Shedding light on zwitterionic magnetic nanoparticles: limitations for in vivo applications. |
| Q90675648 | Single-Dimer Formation Rate Reveals Heterogeneous Particle Surface Reactivity |
| Q30354257 | Site-Specific Modulation of Charge Controls the Structure and Stimulus Responsiveness of Intrinsically Disordered Peptide Brushes |
| Q27300748 | Size Dependent Kinetics of Gold Nanorods in EPR Mediated Tumor Delivery |
| Q95643273 | Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow |
| Q89985210 | Size-Tunable Strategies for a Tumor Targeted Drug Delivery System |
| Q33794267 | Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery |
| Q64071894 | Solid Lipid Nanoparticles Surface Modification Modulates Cell Internalization and Improves Chemotoxic Treatment in an Oral Carcinoma Cell Line |
| Q48186975 | Solid Phase Stepwise Synthesis of Polyethylene Glycols. |
| Q93190432 | Sonochemical One-Step Synthesis of Polymer-Capped Metal Oxide Nanocolloids: Antibacterial Activity and Cytotoxicity |
| Q37188771 | Spherical nucleic acid targeting microRNA-99b enhances intestinal MFG-E8 gene expression and restores enterocyte migration in lipopolysaccharide-induced septic mice |
| Q58577190 | Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution |
| Q38663895 | Strategies to enhance the distribution of nanotherapeutics in the brain |
| Q89919852 | Surface Chemistry-Dependent Evolution of the Nanomaterial Corona on TiO2 Nanomaterials Following Uptake and Sub-Cellular Localization |
| Q91660612 | Surface PEGylation suppresses pulmonary effects of CuO in allergen-induced lung inflammation |
| Q38899902 | Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges. |
| Q64253334 | Synergistic Effect of Low Molecular Weight Polyethylenimine and Polyethylene Glycol Components in Dynamic Nonviral Vector Structure, Toxicity, and Transfection Efficiency |
| Q92990066 | Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles |
| Q55114331 | Synthesis of Controlled-Size Silica Nanoparticles from Sodium Metasilicate and the Effect of the Addition of PEG in the Size Distribution. |
| Q47589446 | Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications |
| Q47301464 | Synthesis, characterization and in vitro release performance of the pegylated valnemulin prodrug |
| Q55003285 | Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo. |
| Q90645526 | Tantalum oxide nanoparticles as versatile contrast agents for X-ray computed tomography |
| Q90178947 | Targeted Delivery of Secretory Promelittin via Novel Poly(lactone-co-β-amino ester) Nanoparticles for Treatment of Breast Cancer Brain Metastases |
| Q92628160 | Targeted Drug Delivery in Lipid-like Nanocages and Extracellular Vesicles |
| Q99630296 | Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis |
| Q49787181 | Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer. |
| Q61812652 | Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells |
| Q41654070 | Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles |
| Q55257510 | Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model. |
| Q46243656 | Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases. |
| Q89553011 | The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation |
| Q58803479 | The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery |
| Q90543446 | The Well-Developed Mucosal Immune Systems of Birds and Mammals Allow for Similar Approaches of Mucosal Vaccination in Both Types of Animals |
| Q37210936 | The delivery of therapeutic oligonucleotides |
| Q39350747 | The particle in the spider's web: transport through biological hydrogels. |
| Q59809737 | Thin-Shelled PEGylated Perfluorooctyl Bromide Nanocapsules for Tumor-Targeted Ultrasound Contrast Agent |
| Q90811674 | Time Interval of Two Injections and First-Dose Dependent of Accelerated Blood Clearance Phenomenon Induced by PEGylated Liposomal Gambogenic Acid: The Contribution of PEG-Specific IgM |
| Q47965414 | Topical delivery of TRPsiRNA-loaded solid lipid nanoparticles confer reduced pain sensation via TRPV1 silencing, in rats. |
| Q47189597 | Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles |
| Q64062363 | Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment |
| Q92070820 | Triamcinolone Acetonide-Loaded PEGylated Microemulsion for the Posterior Segment of Eye |
| Q91215241 | Tumor Contrast Imaging with Gas Vesicles by Circumventing the Reticuloendothelial System |
| Q90737393 | Tumor Targeted Nanocarriers for Immunotherapy |
| Q92478765 | Tunable Composition of Dynamic Non-Viral Vectors over the DNA Polyplex Formation and Nucleic Acid Transfection |
| Q97531133 | Ultrasmall Mixed Eu-Gd Oxide Nanoparticles for Multimodal Fluorescence and Magnetic Resonance Imaging of Passive Accumulation and Retention in TBI |
| Q64961990 | Understanding the Nano-bio Interfaces: Lipid-Coatings for Inorganic Nanoparticles as Promising Strategy for Biomedical Applications. |
| Q37518724 | Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles |
| Q64941032 | Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery. |
| Q57954105 | Versatile “click” synthesis of 1-hydroxy-1,1-methylenebisphosphonic acids with thioalkoxy substituents for the preparation of stable gold nanoparticles |
| Q91620415 | ZnO nanocrystals derived from organometallic approach: Delineating the role of organic ligand shell on physicochemical properties and nano-specific toxicity |
| Q36271285 | Zwitterionic gold nanorods: low toxicity and high photothermal efficacy for cancer therapy |
| Q47815925 | iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. |
| Q92187150 | iRGD: A Promising Peptide for Cancer Imaging and a Potential Therapeutic Agent for Various Cancers |
| Q60719584 | pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells |
Search more.